Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CYT Company Profile and Key Details

NASDAQ : CYT

Cyteir Therapeutics, Inc.

$3.02
-0.07-2.27%
At Close 4:00 PM
Not Actively Trading
60.62
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

CYT Stock Price Chart

Stock Price Today

Cyteir Therapeutics, Inc. (CYT) stock declined over -2.27%, trading at $3.02 on NASDAQ, down from the previous close of $3.09. The stock opened at $3.03, fluctuating between $3.00 and $3.09 in the recent session.

Stock Snapshot

3.09
Prev. Close
3.03
Open
108.71M
Market Cap
36M
Number of Shares
3
Day Low
3.09
Day High
-3.247311827956989
P/E Ratio
30.09%
Free Float in %
-0.93
EPS (TTM)
3.47
Book Value
-0.72
Cash Flow per Share
1.01M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Apr 12, 20243.013.013.013.010
Apr 11, 20243.013.013.013.010
Apr 10, 20243.013.013.013.010
Apr 09, 20243.013.013.013.010
Apr 08, 20243.013.013.013.010
Apr 05, 20243.013.013.013.010
Apr 04, 20243.013.013.013.010
Apr 03, 20243.013.013.013.010
Apr 02, 20243.013.013.013.010
Apr 01, 20243.013.013.013.010
Mar 28, 20243.013.013.013.010
Mar 27, 20243.013.013.013.010
Mar 26, 20243.013.013.013.010
Mar 25, 20243.013.013.013.010
Mar 22, 20243.013.013.013.010
Mar 21, 20243.013.013.013.010
Mar 20, 20243.013.013.013.010
Mar 19, 20243.013.013.013.010
Mar 18, 20242.973.192.923.01551.4K
Mar 15, 20243.033.093.003.021.01M

Contact Details

Lexington, MA 02421

United States

Website: https://cyteir.comContact: 857 285 4140

About Company

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company is also developing CYT-1853, which is in preclinical trials for solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.

Company Information

Employees46
Beta0.1
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Cyteir Therapeutics, Inc. (CYT) stock price?
Cyteir Therapeutics, Inc. (NASDAQ: CYT) stock price is $3.02 in the last trading session. During the trading session, CYT stock reached the peak price of $3.09 while $3.00 was the lowest point it dropped to. The percentage change in CYT stock occurred in the recent session was -2.27% while the dollar amount for the price change in CYT stock was -$0.07.
CYT's industry and sector of operation?
The NASDAQ listed CYT is part of Biotechnology industry that operates in the broader Healthcare sector. Cyteir Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of CYT?
Dr. Markus F. Renschler M.D.
Pres, Chief Executive Officer & Director
Mr. Timothy Romberger
Independent Director
Mr. David G. Gaiero
Chief Financial Officer
Dr. Krisztina Nemenyi Ph.D.
Senior Vice President of Regulatory Affairs and Quality
Mr. Adam M. Veness Esq.
Gen. Counsel & Sec.
Dr. Paul Secrist Ph.D.
Chief Scientific Officer
Ms. Lisa A. Hayes
Vice President of Investor Relations & Corporation Communications
Dr. Jean-Marc Lapierre Ph.D.
Senior Vice President of Chemistry
Dr. Judson Englert M.D., Ph.D.
Senior Vice President of Clinical R&D
Dr. Kevin Mills Ph.D.
Co-Founder
Dr. Tom O'Shea Ph.D.
Senior Vice President of Clinical Pharmacology & Preclinical Devel.
Ms. Gale Cohen
Vice President of HR
How CYT did perform over past 52-week?
CYT's closing price is 83.03% higher than its 52-week low of $1.65 where as its distance from 52-week high of $3.19 is -5.33%.
How many employees does CYT have?
Number of CYT employees currently stands at 46.
Link for CYT official website?
Official Website of CYT is: https://cyteir.com
How do I contact CYT?
CYT could be contacted at phone 857 285 4140 and can also be accessed through its website. CYT operates from 128 Spring Street, Lexington, MA 02421, United States.
How many shares of CYT are traded daily?
CYT stock volume for the day was 1.01M shares. The average number of CYT shares traded daily for last 3 months was 167.62K.
What is the market cap of CYT currently?
The market value of CYT currently stands at $108.71M with its latest stock price at $3.02 and 36M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Categories

InvestingCrypto NewsMarket NewsBusinessUS Stocks

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades and Downgrades52 Week Highs LowsUnusual VolumeDividend CalenderEarnings Calender
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph